Clinical Trial Update: Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of a new antiviral to prevent CMV reactivation in bone marrow transplant patients; study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection in Immunocompromised Patients
• Cytomegalovirus Reactivation

Drugs mentioned

• AiCuris antiviral (unnamed in snippet)

Snippet

Sponsor: AiCuris Anti-infective Cures AG | Conditions: HCMV Reactivation or HCMV End-Organ Disease | Phase 2 | Status: COMPLETED | Results posted: 2018-02-13